Uniqgene
PrivateLast Round
Accelerator
Sep 26, 2025
Total Funding Raised
$185,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Uniqgene is a biotechnology company that provides personalized wellness and performance solutions through genetic testing and AI-driven insights.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sports & Fitness, Precision Medicine, Sports Analytics, D2C Brands
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uniqgene Comparables
Compare Uniqgene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muhdo Health | 80% | |
| FitnessGenes | 78% | |
| Genomelink | 75% |
Uniqgene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 26, 2025 | ||||
| Seed | Dec 15, 2022 | ||||
| Grant | Dec 8, 2022 |
Uniqgene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innogate | Grant |
| P4 Precision Medicine Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Sep 26, 2025
Received funding from P4 Precision Medicine Accelerator.
Uniqgene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Uniqgene's valuation, stock price, and market status.
Is Uniqgene a public or private company?
Uniqgene is a private company.
What is the current stock price of Uniqgene?
Uniqgene is a private company with no public stock price. Caplight tracks Uniqgene's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Uniqgene worth (valuation)?
Valuation information for Uniqgene is not publicly available.
Can I buy Uniqgene stock?
Uniqgene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Uniqgene's last funding round?
Uniqgene's most recent funding round was Accelerator on September 26, 2025.
Who are the main investors in Uniqgene?
Key investors in Uniqgene include Innogate, P4 Precision Medicine Accelerator.
Will Uniqgene IPO soon?
No public IPO plans have been announced for Uniqgene.
How can I track Uniqgene secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Uniqgene's secondary market activity and sign up for updates.